Back to the companies list
Company information
| Website | https://www.panaceabiotec.com |
| Headquarters Address | B-1 Extn.G-3 Mohan-Cooperative Industrial Estate Mathura Road New Delhi-I10044, India |
| Manufacturing Address | Drug Substance Facility: Ambala Chandigarh Highway Lalru – 140501, Punjab, India | Drug Product Facility: Malpur, Baddi, Dist.Solan Himachal Pradesh- |
| Year founded | 1984 |
Contact information
| Contact name | Dr. Rajesh Jain, Managing Director or Harshet Jain, Business Development |
| Contact email | rajeshjain@panaceabiotec.com, or harshetjain@panaceabiotec.com |
| Contact tel | 00-91-11-41679001, 00-91-11-41 |
| Secondary contact name | Rajinder Kumar Suri, Chief Executive Biologicals |
| Secondary contact email | rksuri@panaceabiotec.com |
| Secondary contact tel | 00-91-11-41679027 or 00-91-981 |
Quality and Regularity Information
| ISO 9001 or 14001 Certification | Not established |
| GMP Certificate | cGMP, WHO PQ |
Product type Expertise
| Number of Live or attenuated viral vaccines | 1 | Live vaccines use a weakened (or attenuated) form of the germ that causes a disease. (examples: Measles, Mumps, Rubella, Rotavirus, Smallpox, Yellow Fever) |
| Number of Inactivated viral vaccines | 1 | Inactivated vaccines use the killed version of the germ that causes a disease (examples: Hepatits A, influenza, Polio, Rabies) |
| Subunit, recombinant, polysaccharide, and conjugate vaccines | 2 | Subunit, recombinant, polysaccharide, and conjugate vaccines use specific pieces of the germ — like its protein, sugar, or capsid (a casing around the germ) (examples Hepatitis B, HPV, HiB, Pneumococcal, Meningoccal) |
| Number of Toxoid (inactivated toxin) vaccines | 2 | A toxin (harmful product) made by the germ that causes a disease (example, Diphtheria, Tetanus) |
| Other Product Types | 7 | |
Capability to Fill Various Container(s)
| Glass Syringe |
| Glass Vials |
| Plastic Vial |
| Ampoule |
| Plastic Dropper |
Special Capabilities
| Adjuvants |
| Preservatives |
| Lyophilization |
| Spray Dry |
| Conjugation |
Capacity available for Collaboration
| Analytical Testing |
| Drug Substance Production |
| Drug Product Production |
| Secondary Packaging |
